Skip to main content
. Author manuscript; available in PMC: 2011 Mar 30.
Published in final edited form as: CNS Drugs. 2009;23(2):171–180. doi: 10.2165/00023210-200923020-00006

Table 2.

Relative Risk Estimates* of the Associations Between Selected Potential Confounders and Death in Elderly Populations from the Medical Literature.

Potential confounder variables
Obesity (BMI ≥ 30) Smoking (current vs. never) ADL score (≥ 1 points) Cognitive impairment (yes vs. no) Rosow-Breslau (≥1 impairments)
EPESE studies 3.70 1.37
Branch et al. 3.66
Ramos et al. § 3.00
Corrada et al. 1.12
Freedman et al. 1.15
Hu et al. ¥ 1.69
Doll et al. β 2.50
Dewey et al. Ψ 2.63
Mean 1.32 2.50 3.45 2.63 1.37
*

In case of conflicting literature estimates the mean estimate was used.

From the Duke and Iowa Established Populations for Epidemiologic Studies of the Elderly (EPESE), 10,297 community-dwelling adults 65 years and older.28 The relative rate estimate of 3.7 for ADL score is the average estimate of the odds ratios for East Boston (4.0), Iowa (4.2), and New Haven (3.0, see Table 2 of original paper). The relative rate of 1.37 for the Rosow-Breslau Score is an estimate from the curves on Figure 3 of the original paper.

From a prospective study on 1,625 community-dwelling elderly (age 65+) in Massachusetts, Table 2.29

§

From a sample of 1,667 older (age 65+) urban residents in Brazil, Table 2.30

From a sample of 13,978 elderly residents in a retirement community in California, Table 2.31

From a nationwide US cohort of 83,744 radiologic technologists aged 55+.32 The relative risk of 1.15 was calculated from data provided in Table 3 of original paper.

¥

From a cohort of 116,564 female registered nurses in the US.33 Relative risk of 1.69 was calculated from exposure and death data provided in Table 3 of original article.

β

From the 50-year longitudinal study of 34,439 male British doctors.34 Relative risk of 2.50 was calculated as the average from the mortality ratio of doctors aged 65-74 years (2.7) and mortality ratio of doctors aged 75-84 years (2.2), provided in Table 5 of original paper.

Ψ

From a review of the available literature on cognitive impairment and mortality in community-dwelling elderly (age 65+), Table 4.35